Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), Sarah Spreckelmeyer(Humboldt-Universität zu Berlin), Clemens Decristoforo(Innsbruck Medical University), Peter Caravan(Harvard University), Sietske Rubow(Stellenbosch University), Marcela Zubillaga(Universidad de Buenos Aires), Giuseppe Carlucci(UCLA Health), Xing Yang(Nanjing Tech University), Tamer M. Sakr(Egyptian Atomic Energy Authority), Jeroen J. M. A. Hendrikx(Slotervaartziekenhuis), Antony D. Gee(St Thomas' Hospital), Jan Rijn Zeevaart(South African Nuclear Energy Corporation (South Africa)), Mohammed Al‐Qahtani(King Khalid University), Adriano Duatti(University of Ferrara), Guy Bormans(KU Leuven), Hua Yang(TRIUMF), Hongmei Jia(Beijing Normal University), Junbo Zhang(Chengdu University of Traditional Chinese Medicine), Ralph Santos Oliveira(Nuclear Engineering Institute), Wiktor Szymański(University Medical Center Groningen), Miguel Avila Rodriquez(Universidad Nacional Autónoma de México), Robert H. Mach(California University of Pennsylvania)
EJNMMI Radiopharmacy and Chemistry
October 27, 2023
Cited by 1


Related Papers